We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.33B
AUM Growth
+$1.69B
Cap. Flow
+$1.15B
Cap. Flow %
15.72%
Top 10 Hldgs %
11.92%
Holding
611
New
202
Increased
183
Reduced
174
Closed
49

Top Sells

Rank Stock Value
1
DT icon
Dynatrace
DT
+$106M
2
SPXC icon
SPX Corp
SPXC
+$28.8M
3
EQC
Equity Commonwealth
EQC
+$25.2M
4
GIL icon
Gildan
GIL
+$24.7M
5
ICUI icon
ICU Medical
ICUI
+$17.3M

Sector Composition

Rank Sector Weight
1 Industrials 19.48%
2 Technology 18.29%
3 Financials 14.4%
4 Healthcare 13.59%
5 Consumer Discretionary 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KT icon
526
KT
KT
$8.75B
$758K 0.01%
49,300
TPB icon
527
Turning Point Brands
TPB
$1.56B
$755K 0.01%
17,500
-44,572
-72% -$1.7M
HNI icon
528
HNI Corp
HNI
$3.43B
$753K 0.01%
13,987
+287
+2% +$14.6K
GSSC icon
529
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.06B
$746K 0.01%
+10,755
New +$720K
PBR icon
530
Petrobras
PBR
$123B
$722K 0.01%
50,100
+2,400
+5% +$35.3K
INVA icon
531
Innoviva
INVA
$1.53B
$715K 0.01%
+37,039
New +$683K
ADM icon
532
Archer Daniels Midland
ADM
$37.6B
$699K 0.01%
+11,700
New +$713K
GLPI icon
533
Gaming and Leisure Properties
GLPI
$12.7B
$693K 0.01%
+13,474
New +$667K
KNSA icon
534
Kiniksa Pharmaceuticals
KNSA
$5.73B
$675K 0.01%
+27,026
New +$658K
VEA icon
535
Vanguard FTSE Developed Markets ETF
VEA
$230B
$627K 0.01%
+11,882
New +$604K
ACT icon
536
Enact Holdings
ACT
$6.68B
$622K 0.01%
17,131
+357
+2% +$12.2K
WIT icon
537
Wipro
WIT
$20.3B
$610K 0.01%
+188,200
New +$589K
RSPT icon
538
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.57B
$603K 0.01%
+16,000
New +$583K
BAND
539
Bandwidth Inc
BAND
$1.4B
$593K 0.01%
33,889
-54,798
-62% -$971K
CG icon
540
Carlyle Group
CG
$17.6B
$560K 0.01%
+13,000
New +$545K
PFFD icon
541
Global X US Preferred ETF
PFFD
$2.17B
$534K 0.01%
+25,677
New +$517K
KVUE icon
542
Kenvue
KVUE
$36.5B
$516K 0.01%
+22,288
New +$462K
VRP icon
543
Invesco Variable Rate Preferred ETF
VRP
$3B
$510K 0.01%
+20,862
New +$504K
AB icon
544
AllianceBernstein
AB
$3.46B
$492K 0.01%
+14,100
New +$482K
PCRX icon
545
Pacira BioSciences
PCRX
$1.06B
$483K 0.01%
+32,061
New +$548K
CIG icon
546
CEMIG Preferred Shares
CIG
$6.24B
$461K 0.01%
223,990
+86,600
+63% +$173K
NU icon
547
Nu Holdings
NU
$69.8B
$446K 0.01%
+32,702
New +$440K
CPSS icon
548
Consumer Portfolio Services
CPSS
$208M
$445K 0.01%
+47,434
New +$442K
DLX icon
549
Deluxe
DLX
$1.23B
$404K 0.01%
20,729
+7
+0% +$146
SXC icon
550
SunCoke Energy
SXC
$714M
$395K 0.01%
45,529
-434,066
-91% -$4.02M

Similar funds

Segall Bryant & Hamill's Q3 2024 Portfolio in Review

As of Q3 2024, Segall Bryant & Hamill held 611 positions worth $7.33B, up 30% from $5.64B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Segall Bryant & Hamill deployed $1.15B of net new capital in Q3 2024, opening 202 new positions and adding to 183 existing holdings. Its largest new stake was NVIDIA: 687,551 shares worth $83.5M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was SPX Corp, an estimated $28.8M trimmed.

  • Segall Bryant & Hamill's largest Q3 2024 buy was NVIDIA: 687,551 shares worth $83.5M.
  • Segall Bryant & Hamill added most to Microsoft in Q3 2024, an estimated $91.1M increase.
  • Segall Bryant & Hamill's biggest Q3 2024 reduction was SPX Corp, cutting an estimated $28.8M.
  • Segall Bryant & Hamill fully exited Dynatrace in Q3 2024, selling an estimated $106M.
  • Segall Bryant & Hamill's ten largest holdings make up 12% of its $7.33B portfolio in Q3 2024.
  • Segall Bryant & Hamill opened 202 new positions and closed 49 in Q3 2024.
  • Segall Bryant & Hamill's portfolio value rose 30% quarter-over-quarter to $7.33B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2024, filed 8 Nov 2024.